0001179110-20-000268.txt : 20200103
0001179110-20-000268.hdr.sgml : 20200103
20200103213206
ACCESSION NUMBER: 0001179110-20-000268
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Backstrom Jay T.
CENTRAL INDEX KEY: 0001796398
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 20507929
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2020-01-02
0
0001280600
ACCELERON PHARMA INC
XLRN
0001796398
Backstrom Jay T.
128 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Research and Development
Common Stock
2020-01-02
4
A
0
17107
0
A
17107
D
Option to Purchase Common Stock
52.61
2020-01-02
4
A
0
94865
0
A
2030-01-02
Common Stock
94865
94865
D
The shares of common stock underlying this stock option award vest as to 25% of the shares on the first anniversary of January 1, 2020 and the remaining shares vest in equal quarterly installments over the following three years thereafter.
/s/ Adam M. Veness, as attorney-in-fact for Jay T. Backstrom
2020-01-03